The Exchange has sought clarification from Godrej Agrovet Limited with respect to recent news item captioned Godrej Agrovet expanding product portfolio, strengthening distribution networks in North and East for Crop Protection biz. The response from the Company is attached.
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godrej Agrovet responded to NSE's query about a March 2, 2026 Hindu Business Line article stating the company was expanding its product portfolio and distribution in North and East India for its Crop Protection business. The company stated that no undisclosed material developments exist requiring disclosure under SEBI's Listing Regulations. It said there is no material impact from the article and confirmed full compliance with disclosure norms. As supporting evidence, the company attached its Q3 FY26 investor presentation and an earlier intimation about the launch of its new insecticide TAKAI for rice crops. The attached financials show consolidated Q3 FY26 revenue of ₹2,718 Cr (up 11% YoY), EBITDA of ₹260 Cr (up 13.6%), and PBT of ₹169 Cr (up 23.1%).
This is a routine stock exchange clarification confirming no undisclosed price-sensitive information. The stock is unlikely to see a sharp reaction; investors should focus on the underlying Q3 results which show healthy growth in Animal Feed, Vegetable Oil, and Astec Lifesciences, partly offset by margin pressure in Crop Protection and Dairy.